Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Presentations Poster Category 1

Bone

Genetic Diagnosis Using Whole Exome Analysis in Two Cases with Malign Infantile Osteopetrosis
aDr Behcet Uz Children Hospital, Izmir, Turkey; bIntergen Genetic Center, Ankara, Turkey
hrp0084p1-12
Osteogenesis Imperfecta: A Pilot Trial on Treatment with the RANKL-Antibody Denosumab
aUniversity Cologne Children’s Hospital, Cologne, Germany; bInstitute of Human Genetics, University of Cologne, Cologne, Germany
hrp0084p1-13
No Secular Trend in Vitamin D Levels Over the Past 30 Years in Swedish Children
aDepartment of Physiology/Endocrinology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden; bDepartment of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy, Göteborg Pediatric Growth Research Centre (GP-GRC), University of Gothenburg, Göteborg, Sweden; cDepartments of Clinical Chemistry, Clinical and Experimental Medicine, Linköping, Sweden
hrp0084p1-14
Lithium Chloride Prevents Glucocorticoid-Induced Growth Failure in Cultured Foetal Rat Metatarsal Bones
aKarolinska Institutet, Stockholm, Sweden; b2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic
hrp0084p1-15
Humanin Prevents Undesired Apoptosis of Chondrocytes without Interfering with the Anti-Inflammatory Effect of Dexamethasone in a Model of Arthritis
aPediatric Endocrinology Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Astrid Lindgren Children’s Hospital, 171 76 Stockholm, Sweden; bRheumatology, Karolinska Institutet, Centre for Molecular Medicine, L8:04, 171 77 Stockholm, Sweden
hrp0084p1-17
Response to Vitamin D Replacement is Determined by Body Surface Area in Children with Vitamin D Deficiency
aNational Health Corporation, Ilsan Hospital, Goyang, Republic of Korea; bCHA University, Sungnam, Republic of Korea
hrp0084p1-18
Bone-Muscle Unit Assessment with pQCT in Children with Inflammatory Bowel Disease Following Treatment with Infliximab
aDevelopmental Endocrinology Research Group, Glasgow, UK; bDepartment of Paediatric Gastroenterology, Glasgow, UK
hrp0084p1-19
24-Hydroxylase Polymorphism as a Possible Contributor to the Increased 1,25(OH)2D in African Americans
aYale Yniversity, New Haven, Connecticut, USA; bUniversity of Toronto, Toronto, Ontario, Canada; cGenomic Research Center, SBMU, Tehran, Iran
hrp0084p1-20
Effects of Inorganic Phosphate and FGF23 on C2C12 Myoblast Cells
aMedical University Vienna, Vienna, Austria; bUniversity of Veterinary Medicine, Vienna, Austria
hrp0084p1-21
Evaluation of Bone Mineral Density and Microarchitectural Parameters by DXA and HR-PQCT in 36 X-linked Hypophosphatemic Rickets Patients from a Single-Centre Study
aEndocrinology Department, Division of Internal Medicine, Osteometabolic Disorders Unit, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil; bDivision of Internal Medicine, Hormone and Molecular Genetics Laboratory (LIM/42), Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil; cRheumatology Department, Division of Internal Medicine, Bone Metabolism Laboratory (LIM/17), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
hrp0084p1-22